Ben Condon, who was two months old, died at Bristol Children’s Hospital in April 2015 after developing a respiratory illness.
About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company’s drug ...
The inquest into the death of Ben Condon, who died aged two months, heard his family had been referred for an out-of-hours ...
These are known as disease-modifying treatments and have been licensed for private use. Other medications are under review to see if they could be prescribed to people in the very early stages of ...
Acute respiratory distress syndrome (ARDS) is present in >10% of all people admitted to critical care and is associated with severe morbidity and mortality. Despite more than half a century since its ...